Metraipolis › archive › dc_634fb703fe23

Hepatic arterial infusion chemotherapy plus tyrosine kinase inhibitors with or without PD-1 inhibitors for advanced hepatocellular carcinoma with VP4 portal… — Europe PMC PMID:42245629

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42245629
DOI
10.3389/fimmu.2026.1832313
License (as archived)
solo-consultazione
Archived
2026-11-01T13:26:58.764Z
SHA-256 of the archived text
e9b5b0ec7d8d5d04fdba24d4cf10d0298bca801ecb60f1ecc0c36c687f34a371
Stable URL of this page
https://metraipolis.com/documento/dc_634fb703fe23

How to cite

Hepatic arterial infusion chemotherapy plus tyrosine kinase inhibitors with or without PD-1 inhibitors for advanced hepatocellular carcinoma with VP4 portal… — Europe PMC PMID:42245629 — Europe PMC (en), https://europepmc.org/article/MED/42245629 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_634fb703fe23 (Metraipolis archive dc_634fb703fe23, sha256 e9b5b0ec7d8d5d04fdba24d4cf10d0298bca801ecb60f1ecc0c36c687f34a371)
BibTeX
@misc{dc634fb703fe23,
  title = {Hepatic arterial infusion chemotherapy plus tyrosine kinase inhibitors with or without PD-1 inhibitors for advanced hepatocellular carcinoma with VP4 portal… — Europe PMC PMID:42245629},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42245629},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_634fb703fe23; sha256 e9b5b0ec7d8d5d04fdba24d4cf10d0298bca801ecb60f1ecc0c36c687f34a371},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42245629. Agents can read the archived copy with the MCP tool read_document.